chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MMR combination vaccination administered to childcare worker on 6/16/08 after request for mumps booster for negative mumps titer. Recipient reports the following day upon awakening she felt extremely "tired" and "throat started feeling tight" No breathing problems but glands in neck felt swollen and had a sore throat. Five days after vsaccination developed nasal congestion and some shortness of breath. Recipient is asthmatic but did not seek medical attention,and did not have her Albuterol inhaler,"lost it". Now 7 days later chest tightness is relieved but continues to have general malaise.
Stated feeling achy, my daughter got her at same location and time so we were comparing symptoms.
zoster-related inkuries; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medication were not provided. On or about 12-AUG-2014, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dosage regimen was not reported) for the long-term prevention of herpes zoster or shingles. Subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a healthcare provider for shingles or zoster-related injuries. As a direct and proximate result of the use of the zoster vaccine live (ZOSTAVAX), the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; significant medical and related expenses as a result of these injuries, including but not limited to costs for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
This spontaneous report as received from an unknown reporter refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of improperly stored M-M-R II (lot# reported as H018949, EXP date 18-OCT-2014). At the time of report, the status of patient was unknown. Additional information is not expected.
Pain on the back of left hand, also two fngers on left hand have become extremely stiff and hard to bend or use.
Brief HPI and Hospital Course: 67 year old male with unknown past medical history was brought in by EMS as post-cardiac arrest. Patient was found on unresponsive on sidewalk, possible collapse. ACLS started by EMS, approx 10-15 minutes. Initial rhythm was junctional PEA. Was given 2 epi and intubated by EMS and had ROSC, Initial ROSC rhythm was SVT which slowed to 90s on its own. On arrival to ED, left femoral central line placed. Tox screen was positive for cocaine and ETOH. Was placed on ACS protocol for possible NSTEMI. Tested positive for COVID19 on admission. Patient required pressor support on admission. Hypothermia protocol was initiated.  Patient was rewarmed per protocol, normothermic as of 5/5.    Brief Narrative of Events leading to Patient's Death: Patient remained normothermic with persistent septic shock, multi organ failure, ARDS secondary to COVID19. Multiple attempts to reach family members made by ICU team and palliative care team daily without answer. Patient made DNR by two-physician consent. Patient's BP low despite maximum levophed support.
The client denied any side effects or problems after receiving a 2nd ZOSTAVAX on 4-21-10. He did not remember receiving the 1st ZOSTAVAX on 10-31-08, which is on his vaccine Thor record. He called the day before, and drove from the city to receive the second ZOSTAVAX. On 4/21/2010 - the client was given a 2nd ZOSTAVAX.  He had "NO" adverse event from this so that is why the date and time was not completed under that section of the form.
Sick; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023NVX-US-000001165 (RA).  A male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunisation. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Sick".  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Client reported within a couple minutes after receiving the Moderna COVID vaccine he developed dizziness, light sensitivity, headache, and nausea. The client stated the symptoms lasted 6 minutes. The client stated his vision was ?white? for 2-3 minutes. Client stated he was observed at the site and no medication was administered. Client stated later that day he experienced persistent headache, chills, change in taste, and hunger that lasted 1-2 days. Client also reported for one day he had shortness of breath and described the feeling as, "I couldn't fill my lungs." Client reported he didn't take any medication for the symptoms. The client did not follow up with any doctors. The client denied any chronic medical conditions, medications, or known allergies. The client denied any history or syncope.
p/vax pt c/o itchy eye & face red;DPH given;pt still c/o itch-face, arm & chest & nose red;adrenalin given then better;
Child given immunizations of HIB and Prevnar in the right leg on 03/31/05. Patient seen in the office on 04/01/05 with fever of 103-104, right leg swollen 20x30 cm. Need direction on what to give for next immunizations.
I received my second Moderna booster for COVID-19 on 4/26/2022. On either the evening of 7/21/2022 or the morning of 7/22/2022, I developed a cough and some upper respiratory congestion. My husband had recently tested positive for COVID-19, so I just started masking and then took a home test on the evening of 7/23/2022. The result was positive. I just treated my symptoms with OTC medicines like Delsym, Mucinex, and Sudafed. I then called my PCP on 7/25/2022 to notify her. She prescribed me some benzonatate pills to treat my cough. Since I've been ill, I've dealt with significant fatigue, brain fog, cough, and congestion. I've been regularly checking my blood oxygen levels, and they have never dipped below 97%. At the time of this writing, my symptoms are improving. I'm now not as tired as I was from 7/24/2022-7/26/2022, plus my brain fog has diminished. However, I still have cough and congestion. Having said that, though, I would say that the OTC medicines and the benzonatate have worked well. I haven't had difficulty breathing, and I have been able to sleep well at night.
This case was reported by a consumer and described the occurrence of high fever in a 17-month-old female subject who was vaccinated with PEDIARIX. A physician has verified this report. Concurrent vaccination included PREVENAR given on 24 January 2008 at 9:30 the subject inadvertently received a 4th dose of PEDIARIX rather than the planned dose of INFANRIX. The 4th dose of PEDIARIX was considered to be an extra dose administered. The subject experienced a systemic reaction. On 24 January 2008, an unspecified amount of time after vaccination with PEDIARIX, the subject experienced a high fever. Days later, on 27 January 2008, the subject experienced restless sleep. The fever remained for a few days (number not specified) and then resolved. At the time of reporting, restless sleep was unresolved. A physician verified this report in follow-up received on 06 March 2008. Follow-up indicated that the subject was seen on 30 January 2008 with rash, therefore, the possibility of Roseola was brought up as a possible explanation for the fever. Fever lasted from 24 January 2008 to 26 January 2008 with rash starting that day. The maximum temperature for the subject was 103 degrees.
Headache, Myalgia, Arthralgia, Fever, ErythemaMultiform,  Pain, chills  Narrative:
experienced mild upper arm tenderness at the injection site; experienced mild fatigue; increase in temperature (99.9 F); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient received bnt162b2 (BNT162B2), administered in arm, administration date 12Mar2021 11:00 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "valvular heart disease" (unspecified if ongoing). There were no concomitant medications. The following information was reported: Vaccination site tenderness (non-serious) with onset 12Mar2021 18:00, outcome "recovered" (Mar2021), described as "experienced mild upper arm tenderness at the injection site"; FATIGUE (non-serious) with onset 12Mar2021 18:00, outcome "recovered" (Mar2021), described as "experienced mild fatigue"; BODY TEMPERATURE INCREASED (non-serious) with onset 12Mar2021 18:00, outcome "recovered" (Mar2021), described as "increase in temperature (99.9 F)". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
There were no observed adverse events; however, patient has history of reaction to Dtap and was given a Tdap. She was examined approximately one hour after the vaccine.
right hand weakness (no sensory loss) in a multi-focal distribution (radial, ulnar) - C8. Sensation and reflexes intact; This is a spontaneous report from a contactable physician. A male patient of unspecified age (Cardiologist) received 2 single doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified dates, for COVID-19 immunization. Medical history and concomitant medications were not reported. During the next four days after the second vaccine dose, since an unspecified date, the patient developed right hand weakness (no sensory loss) in a multi-focal distribution (radial, ulnar) - C8. Sensation and reflexes were intact. MRI of the cervical spine was unrevealing. EMG/NCV study was being scheduled. Event outcome was unknown. Information on the lot/batch number has been requested.
I experienced a large red area at the injection site that was itchy and painful to the touch.  I believe it's what's referred to as "COVID arm."
Reports developing progressive hives approx. 2 hours following vaccine, accompanied by feeling throat constricted.
Patient is 16 years old and received the vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 16 years old and received the vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 16 years old and received the vaccine). On 08-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is 16 years old and received the vaccine) had resolved. Unknown          no concomitant medications reported. no treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Mar-2021: Additional information received on 11-MAR-2021, No new information found.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old d female) for mRNA-1273 (lot number 013A21A) with no associated AEs reported.
Pfizer vaccine was diluted with 1.5ml instead of 1.8ml.
Arm Pain; Headache; Fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (esophageal). Concomitant products included FAMOTIDINE for Acid reflux (esophageal).   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 14-Mar-2021, PAIN IN EXTREMITY (Arm Pain), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: TCR
Patient has a history of fainting with vaccinations or needles at her doctors office.  Patient let us know of this ahead of time, and also that this was her first time receiving the flu shot to her knowledge.  Immediately after receiving the vaccination, patient stated she felt light-headed and like she was going to faint, so we advised her to remain seated and elevated her legs.  She then stated she began to feel that her vision was becoming blurred, at which point we had called 911 to assess her.  Paramedics arrived and assessed the patient, she began feeling a bit nauseous as well, her BP was 85/50, however they checked her online medical record on her phone and noticed her BP is normally quite "low".  They felt she was improving and advised her she did not need further medical treatment/supervision.
6MAR98 temp 99;7MAR98 sparse red rash chest;11MAR98 red rash over entire body;12MAR98 child saw MD put on antihistamine rash fading;pt lower abd & genital area has pus appearing where rash is present;
Injection site is red, swollen, itchy, painful, hard, warm to touch and getting bigger
1 week from vaccination pt woke with small red rash near injection site. Started cold compress, ibuprofen, ZYRTEC. Redness spread to elbow with "heat" in at as well as bright color. Pt saw MD on 11/30, symptoms had already decreased, no other meds prescribed. Continuing to improve.
Pt came to the office with fever and thrombocytopenia. She had bruises on legs where she was held for shots - pt had never bruised before.
The patient presented to hospital with anaphylaxis without clear precipitating cause, possibly secondary to Pfizer COVID 19 vaccine. She presented to hospital on 5/22 with a lacy rash over the entire body and a change in her voice with a sensation that she couldn't breathe. She was given several doses of epinephrine, and steroids and improved, and was admitted to medicine for observation.  She reported getting initially COVID-19 vaccine dose on 4/19/21. Thereafter had lacy rash over entire body for 3 days which she took as needed benadryl with improvement. After her second dose on 5/10/21 she initially had no symptoms. Approximately 6-7 days after her second dose lacy whole-body rash returned, worse than when she initially had it after first vaccine dose. She took benadryl several times but rash worsened. She had an odd sensation in her throat and noticed a change in the tone of her voice, and felt like she was having difficulty breathing. She presented to the emergency department.
I took my First Covid shot last Saturday and have been getting sick every since; dizziness; cold symptoms; ear aches; I'm getting severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I took my First Covid shot last Saturday and have been getting sick every since), DIZZINESS (dizziness), NASOPHARYNGITIS (cold symptoms), EAR PAIN (ear aches) and HEADACHE (I'm getting severe headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I took my First Covid shot last Saturday and have been getting sick every since), DIZZINESS (dizziness), NASOPHARYNGITIS (cold symptoms), EAR PAIN (ear aches) and HEADACHE (I'm getting severe headaches). At the time of the report, ILLNESS (I took my First Covid shot last Saturday and have been getting sick every since), DIZZINESS (dizziness), NASOPHARYNGITIS (cold symptoms), EAR PAIN (ear aches) and HEADACHE (I'm getting severe headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.
spitting up phlegm; upset tummy; vomiting; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (spitting up phlegm), ABDOMINAL DISCOMFORT (upset tummy), VOMITING (vomiting) and NAUSEA (nausea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PRODUCTIVE COUGH (spitting up phlegm), ABDOMINAL DISCOMFORT (upset tummy), VOMITING (vomiting) and NAUSEA (nausea). At the time of the report, PRODUCTIVE COUGH (spitting up phlegm), ABDOMINAL DISCOMFORT (upset tummy), VOMITING (vomiting) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported . No treatment information was provided. .   This case was linked to MOD21-050084, MOD-2021-039826 (E2B Linked Report).; Sender's Comments:  MOD21-050084, MOD-2021-039826:patient case
Information has been received from a physician concerning an 11 year old female patient who in July 2008 "6 months ago" was vaccinated with the first dose of GARDASIL (lot # not reported). It was reported that the patient developed skin tags under each of her arms a few days after receiving her first dose of GARDASIL. It was reported that the number of skin tags increased after receiving her second dose. The patient sought unspecified medical attention. Additional information has been requested.
Patient specifically told administering RN that she was pregnant and would need preservative free vaccine, RN consulted another nurse (not a physician) and told patient it was fine. Spoke w/OBGYN and CDC. Advised to report. 11/9/09 Vaccination record received and updated.  11/30/2009 OB-GYN records, preganant patient with no reported se's to vaccine.
Patient states she developed a fever two days after vaccine was administered. Temperature was not measured by patient. Temp is unknown.
NASAL CONGESTION Narrative:  PT ADMITTED TO HOSPITAL 4 DAYS AFTER COVID POSITIVE TEST WITH TACHYPNEA, FEVER, COUGHING, SHORTNESS OF BREATH. FOUND TO HAVE ELEVATED TROPONINS. HOSPITALIZED FROM 3/17 TO 3/31/21. He was admitted to the medical ward and started on Treatment with Dexamethasone and IV Remdesivir, was tolerating the treatment well but the corticosteroids lead to a significant increase in his blood sugars; transferred to the MICU on 03/21 for treatment with an insulin drip. In the ICU patient received treatment with Tocilizumab. His clinical condition continued to improve and he was transferred out of the MICU on 03/24. Patient was monitored on the Step down unit and Oxygen was titrated off as tolerated until he was able to wean off completely. He remained in stable condition and subsequently discharged home to complete a Prednisone Taper.
injection site reaction; full body itching; allergic reactions to the ingredients in Flublok; Initial information was received on 19-Oct-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age female patient who experienced injection site reaction, full body itching and allergic reactions to the ingredients in flublok while receiving vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (dose, formulation, strength, lot and expiry date: unknown) via intramuscular route in unknown administration site for prophylaxis vaccination.  On 19-OCT-2022 the patient developed a non-serious injection site reaction, full body itching (pruritus) and  allergic reactions to the ingredients in flublok (hypersensitivity) (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.   Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK) was not applicable.  It was not reported if the patient received a corrective treatment for the events (injection site reaction, full body itching, allergic reactions to the ingredients in Flublok).  At time of reporting, the outcome was Unknown for all events
On day 5, I developed a rash.  I took Benadryl which seemed to help,  On day 10, is became inflamed and I call my primary care doctor, he prescribed Prednisone 20 mg and told me to report my reaction.  Today is day 12 and I still have a rash.
Left arm soreness on same day/night; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at the age of 54-year-old, via an unspecified route of administration, administered in left arm on 15Feb2021 13:00 (Batch/Lot Number: EN9581) as single dose for COVID-19 immunisation. Medical history included treated with high blood pressure. Concomitant medication included lisinopril taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. The patient experienced left arm soreness on same day/night on 15Feb2021 19:30 with outcome of recovered. No treatment was given for the event.
Approximately 5 hours after the injection my left arm (injection site arm) became sore.  The soreness ended on January 3rd.  No treatment was needed.    On January 1st I noticed tingling  in both of my legs.   Since then it has gotten worse.  I have tingling in both legs, muscle twitching throughout both legs intermittently, muscle weakness specifically after muscle use, an abnormal skin sensitivity when wearing pants, and a consistent ache throughout my legs.  The symptoms affect me 24 hours a day and create an anxiety that I have not felt before.  It has also adversely affected my sleep.
UrticariaPruritus reported itching at neck area but no difficulty breathing or swallowing Narrative: At approx. 1025 reported mild itching anterior neck area, but no difficulty swallowing or breatting. VS: 02 100%, HR 67 ,BG 138/88 administered 25mg Benedryl PO prn per protocol.